ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ETON Eton Pharmaceuticals Inc

3.45
0.33 (10.58%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Eton Pharmaceuticals Inc NASDAQ:ETON NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.33 10.58% 3.45 3.30 4.04 3.67 3.14 3.14 69,246 01:00:00

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18/10/2022 11:50am

GlobeNewswire Inc.


Eton Pharmaceuticals (NASDAQ:ETON)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Eton Pharmaceuticals Charts.

Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean Brynjelsen, Chief Executive Officer, will present at the LD Micro Main Event XV Conference as follows:

Date:Wednesday, October 26, 2022
Time:6:00PM ET
Register to watch the event here:Click Here
  

The webcast will be accessible via the Company’s website at https://ir.etonpharma.com/ in the Investors section under Events and Presentations.

Eton will be participating in 1x1 meetings, which can be requested through your LD Micro representative.

About Eton PharmaceuticalsEton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing, acquiring, and commercializing treatments for rare diseases. The Company currently commercializes ALKINDI SPRINKLE® and Carglumic Acid tablets and has four additional rare disease products under development, including dehydrated alcohol injection and the ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:Lisa M. Wilson, In-Site Communications, Inc.T: 212-452-2793E: lwilson@insitecony.com 

Source: Eton Pharmaceuticals

1 Year Eton Pharmaceuticals Chart

1 Year Eton Pharmaceuticals Chart

1 Month Eton Pharmaceuticals Chart

1 Month Eton Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock